Integra Lifesciences (IART, Financial) experienced a significant drop in stock price, falling 5.00%. The stock is currently trading at $23.57 with a trading volume of 768,216 shares and a turnover rate of 1.00%, with the price fluctuating 5.08%.
Recent financial reports show revenues of $381 million, a net loss of $10.70 million, and an earnings per share of -$0.14. The company reported a gross profit of $214 million and a price-to-earnings ratio of -262.06.
Analysts' ratings indicate mixed signals with 21% recommending a buy, 50% advising hold, and 29% suggesting sell.
In the broader medical device industry, there was a decline of 0.27%. Noteworthy performances in related stocks include significant gains by Pavmed Inc, Paragon 28, Inc., and Alidex, while Bluejay Diagnostics, Inc., Tenon Medical, Inc., and Catheter Precision, Inc. showed high trading activity. The stocks with notable price swings were Pavmed Inc, Inspiremd Inc., and Paragon 28, Inc.
Integra Lifesciences Holdings Corp, based in New Jersey, is a medical device firm specializing in regenerative therapies, orthopedic care, and neurosurgery products. The company operates through two main divisions: Codman Specialty Surgical and Tissue Technologies. While it serves global markets including Europe and Asia-Pacific, the majority of its sales are domestic.
